228 related articles for article (PubMed ID: 34720529)
21. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
[TBL] [Abstract][Full Text] [Related]
22. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
Sreevalsan S; Safe S
Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
[TBL] [Abstract][Full Text] [Related]
23. Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
Abdelrahim M; Baker CH; Abbruzzese JL; Sheikh-Hamad D; Liu S; Cho SD; Yoon K; Safe S
Cancer Res; 2007 Apr; 67(7):3286-94. PubMed ID: 17409437
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells.
Lee HS; Safe S; Lee SO
Toxicol Appl Pharmacol; 2017 Oct; 332():32-39. PubMed ID: 28754437
[TBL] [Abstract][Full Text] [Related]
25. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.
Abdelrahim M; Smith R; Burghardt R; Safe S
Cancer Res; 2004 Sep; 64(18):6740-9. PubMed ID: 15374992
[TBL] [Abstract][Full Text] [Related]
26. Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy.
Sankpal UT; Maliakal P; Bose D; Kayaleh O; Buchholz D; Basha R
Curr Med Chem; 2012; 19(22):3779-86. PubMed ID: 22725697
[TBL] [Abstract][Full Text] [Related]
27. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.
Kim K; Chadalapaka G; Lee SO; Yamada D; Sastre-Garau X; Defossez PA; Park YY; Lee JS; Safe S
Oncogene; 2012 Feb; 31(8):1034-44. PubMed ID: 21765466
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib Targets Sp Transcription Factors in Cancer Cells.
Karki K; Harishchandra S; Safe S
Mol Pharmacol; 2018 Oct; 94(4):1187-1196. PubMed ID: 30115673
[TBL] [Abstract][Full Text] [Related]
29. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
[TBL] [Abstract][Full Text] [Related]
30. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
Mohankumar K; Shrestha R; Safe S
Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
[TBL] [Abstract][Full Text] [Related]
31. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
Higgins KJ; Abdelrahim M; Liu S; Yoon K; Safe S
Biochem Biophys Res Commun; 2006 Jun; 345(1):292-301. PubMed ID: 16678129
[TBL] [Abstract][Full Text] [Related]
32. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.
Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A
PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713
[TBL] [Abstract][Full Text] [Related]
33. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
[TBL] [Abstract][Full Text] [Related]
34. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
[TBL] [Abstract][Full Text] [Related]
35. PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1.
Lacey A; Rodrigues-Hoffman A; Safe S
Cancer Res; 2017 Feb; 77(3):732-741. PubMed ID: 27864345
[TBL] [Abstract][Full Text] [Related]
36. Orphan nuclear receptor 4A1 (NR4A1) and novel ligands.
Safe S; Shrestha R; Mohankumar K
Essays Biochem; 2021 Dec; 65(6):877-886. PubMed ID: 34096590
[TBL] [Abstract][Full Text] [Related]
37. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
Chadalapaka G; Jutooru I; Safe S
Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
[TBL] [Abstract][Full Text] [Related]
38. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
[TBL] [Abstract][Full Text] [Related]
39.
Zhang L; Martin G; Mohankumar K; Hampton JT; Liu WR; Safe S
Mol Pharmacol; 2022 Jun; 102(2):80-91. PubMed ID: 35680166
[TBL] [Abstract][Full Text] [Related]
40. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
Li X; Pathi SS; Safe S
BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
